Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Caring for a Loved One with Cancer

Living with Cancer Pain

Cancer Diagnosis

The Cancer Cell Surface Proteome as a Therapeutic Target

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Cancer Management

Cancer Research

Secondary Brain Cancer

British Pioneers in Cancer Biology

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Cancer Pain

See more featured articles »

Cancer Prognosis

What is Tumorigenesis?

Cancer Glossary

Is Cancer a Metabolic Disorder?

Cancer Pathophysiology

What is Cancer?

Assay for Monitoring and Treating Malignant Brain Tumors

Cancer Classification

Cancer Screening Considerations: Balancing the Benefits and Risks

Cancer Pain Management

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Insight into Cancer Vaccines

Hot vs Cold: the differences between tumor types

Exploiting Enzymes in Cancer Diagnosis and Therapy

Effects of Social and Economic Deprivation on Cancer Mortality

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

What is Merkel Cell Carcinoma?

Cancer Symptoms

What is the Tumor Microenvironment?

What Role do Biobanks Play in Cancer Research?

What is Immunochemotherapy?

Overview of Cell Viability and Cytotoxicity

Targeted Cancer Therapies

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Hypoxia Markers and Their Importance

Cancer History

Microfluidic cancer treatment screen combined with flow cytometry

Pediatric Cancer

CDK9 and Cancer

Extracellular Vesicles as Floating Cancer Biomarkers

Myc Mutations and Cancer

Acidosis and Tumor Progression

The Biochemistry of Breast Cancer Screening

Investigating the Molecular Mechanisms of Cancer

What Causes Cancer?

Insights into Oncofertility

What is Cancer of Unknown Primary?

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Cancer Epidemiology

Metastatic Migration in Cancer may be Influenced by Metabolism

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Using Biomarkers to Detect Cancer

The Effects of Cancer on Family Life

Secondary Lung Cancer

Why are Cancer Cell Lines Useful?

TARDIS: The Improved Method of Detecting Breast Cancer

Cutaneous Manifestations of Internal Malignancy

Cancer Prevention: Lowering your Risk

Transforming Cancer Care through Genomic Testing

Latest Cancer News and Research

AI-designed molecular switch uses caffeine to control engineered cells

For many of us, a warm cup of coffee is how we start our day. For Texas A&M Health researchers, it may also offer a new way to control engineered cells in future medicines.

8 Jun 2026

Brain-targeted estrogen reduces breast cancer treatment side effects

Most breast cancers are worsened by estrogens. To combat the recurrence of these cancers, clinicians treat patients with inhibitors for estrogen production, like letrozole. But many patients do not adhere to this treatment due to negative side effects.

8 Jun 2026

Study identifies new therapeutic candidate for KRAS-driven pancreatic cancer

A new research paper was published in Volume 17 of Oncotarget on June 3, 2026, titled "The anticancer effects of PCAIs in pancreatic cancer cells involve MAPK and PI3K/AKT pathways hyperactivation."

8 Jun 2026

Online tool transforms patient experience in national cancer trials

In a step forward for patient-centered cancer research, a new pilot project reveals that 84% of participants had a positive experience using a newly developed online tool created by the Alliance for Clinical Trials in Oncology called the Participant Engagement Portal (PEP).

8 Jun 2026

Rice University receives CPRIT funding to advance cancer research

New funding from the Cancer Prevention and Research Institute of Texas (CPRIT) will help Rice University advance cancer research on several fronts, from strengthening a core genetic engineering facility that serves researchers across Texas to supporting new studies in cancer immunotherapy and ovarian cancer.

8 Jun 2026

Father's alcohol use before conception impacts offspring development

A growing body of research suggests that a father's health before conception may play a larger role in child development than previously understood - and researchers are working to understand how a father's drinking before conception may affect offspring health and development.

8 Jun 2026

Melanoma disproportionately impacts Florida's senior population

Florida's year-round sunshine and intense ultraviolet (UV) exposure help drive one of the nation's heaviest skin cancer burdens, with older adults shouldering much of the impact.

8 Jun 2026

Defective HIV copies explain persistent viral traces during treatment

Antiretroviral drugs for HIV infection have enabled most people living with the virus to live long and healthy lives.

8 Jun 2026

Infant receives world's first gene therapy for WOREE syndrome

An eight-month-old infant with a severe genetic epilepsy has become the first patient in the world to receive an experimental gene replacement therapy designed to restore the function of the WWOX gene directly in the brain.

8 Jun 2026

DNA study links BRCA genes to aggressive early-onset breast cancer in black women

Black women experience disproportionately elevated risks of developing and dying from early-onset breast cancer. New research published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society, reveals the genes that are most likely to be mutated to contribute to these increased risks.

8 Jun 2026

Researchers develop compound 10 to slow Alzheimer's disease progression

Researchers from ETH Zurich have developed an active ingredient that slows down the progression of typical Alzheimer’s symptoms in mice. This new substance protects nerve cells and could in future alleviate the suffering of Alzheimer’s patients. The active ingredient also shows anti-aging effects.

8 Jun 2026

Weight loss medications show promise in preventing obesity-related cancers

A study of more than 229,000 obese adults without diabetes in the United States has shown that weight loss drugs are associated with a decreased risk of obesity-related cancers.

7 Jun 2026

Infections pose major but overlooked risks in people with diabetes

Infections should be considered a "health hazard" in people living with diabetes, with experts warning that current clinical guidelines fail to reflect a substantial but under-recognized burden of illness, hospitalization and death.

7 Jun 2026

Researchers challenge the traditional understanding of how histone deacetylase inhibitors function

Researchers at Baylor College of Medicine and collaborating institutions are challenging the traditional understanding of how cancer drugs called histone deacetylase (HDAC) inhibitors function.

5 Jun 2026

Popular supplement creatine supercharges critical immune cells fighting cancer

Creatine, the organic acid that is popularly taken as a supplement by athletes and bodybuilders, supercharges a critical class of immune cells that activate and prepare the body's key cancer-fighters, according to new UCLA research.

5 Jun 2026

Study validates research models for tracking circular extra-chromosomal DNA

Damage to DNA in cancer cells can lead to pieces breaking off chromosomes and floating away, like icebergs cracking off from a glacier.

5 Jun 2026

NYU Langone hits milestone with its 1,000th focal cryotherapy procedure

Just two days after his minimally invasive prostate cancer treatment at NYU Langone Health, Broadway performer André De Shields, 80, was back onstage preparing for his next show, Cats: The Jellicle Ball, which debuted in April 2026.

5 Jun 2026

Large clinical trial shows both common septic shock fluids are equal

A randomized clinical trial conducted across five countries in 47 pediatric emergency departments, including Ann & Robert H. Lurie Children's Hospital in Chicago, established that both commonly used IV fluids for treating septic shock – balanced crystalloid fluid and 0.9% saline – are equally safe and effective. Results were published in the New England Journal of Medicine.

5 Jun 2026

Hidden junk DNA could play decisive role in cancer

Many repetitive regions of the genome have been considered "junk DNA" because the technologies available did not allow them to be studied at sufficient resolution.

5 Jun 2026

Review highlights TIGIT as a promising second-generation immunotherapy target

Malignant tumors remain a major threat to human health, with conventional therapies and first-generation immune checkpoint inhibitors (ICIs) facing limitations like drug resistance and low response rates.

5 Jun 2026